X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (87) 87
cancer (64) 64
oncology (60) 60
life sciences (54) 54
middle aged (53) 53
male (52) 52
aged (51) 51
radiotherapy (47) 47
[ sdv.can ] life sciences [q-bio]/cancer (46) 46
female (45) 45
combined modality therapy (43) 43
adult (39) 39
mesh : humans (38) 38
chemotherapy (35) 35
index medicus (35) 35
surgery (35) 35
mesh : aged (24) 24
mesh : middle aged (23) 23
radiation-therapy (23) 23
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
neoplasm staging (22) 22
treatment outcome (22) 22
carcinoma (21) 21
mesh : combined modality therapy (21) 21
mesh : male (21) 21
aged, 80 and over (20) 20
mesh : female (20) 20
rectal neoplasms - radiotherapy (20) 20
disease-free survival (19) 19
care and treatment (18) 18
rectal neoplasms (18) 18
rectal neoplasms - surgery (18) 18
mesh : adult (17) 17
mesh : rectal neoplasms (17) 17
rectal cancer (17) 17
adenocarcinoma (16) 16
radiotherapy dosage (16) 16
rectal neoplasms - pathology (16) 16
chemoradiation (15) 15
chemoradiotherapy (15) 15
chemotherapy, adjuvant (15) 15
hematology, oncology and palliative medicine (15) 15
randomized-trial (15) 15
rectal neoplasms - drug therapy (15) 15
fluorouracil (14) 14
fluorouracil - administration & dosage (14) 14
neoplasm recurrence, local (14) 14
radiation therapy (14) 14
rectal neoplasms - mortality (14) 14
research (14) 14
survival (14) 14
follow-up studies (13) 13
prospective studies (13) 13
randomized controlled trials as topic (13) 13
rectal neoplasms - therapy (13) 13
mesh : treatment outcome (12) 12
preoperative radiotherapy (12) 12
prognosis (12) 12
radiology, nuclear medicine & medical imaging (12) 12
survival analysis (12) 12
adenocarcinoma - radiotherapy (11) 11
adenocarcinoma - surgery (11) 11
cancer therapies (11) 11
esophageal cancer (11) 11
mesh : chemotherapy, adjuvant (11) 11
neoadjuvant therapy (11) 11
total mesorectal excision (11) 11
health aspects (10) 10
irradiation (10) 10
medicine & public health (10) 10
radiation (10) 10
survival rate (10) 10
therapy (10) 10
clinical trials (9) 9
colorectal cancer (9) 9
esophageal neoplasms - radiotherapy (9) 9
follow-up (9) 9
france (9) 9
mesh : adenocarcinoma (9) 9
mesh : disease-free survival (9) 9
mesh : neoplasm recurrence, local (9) 9
phase-iii trial (9) 9
prostate cancer (9) 9
quality of life (9) 9
radiotherapy, adjuvant (9) 9
antineoplastic combined chemotherapy protocols (8) 8
leucovorin - administration & dosage (8) 8
mesh : antineoplastic combined chemotherapy protocols (8) 8
mesh : fluorouracil (8) 8
mesh : neoplasm staging (8) 8
mesh : randomized controlled trials as topic (8) 8
oncology, experimental (8) 8
patients (8) 8
prostatic neoplasms - surgery (8) 8
risk factors (8) 8
adenocarcinoma - drug therapy (7) 7
adenocarcinoma - mortality (7) 7
adjuvant treatment (7) 7
analysis (7) 7
colorectal-cancer (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 145 - 145
145 Background: The PRODIGE 5 trial has demonstrated the safety and the efficacy of FOLFOX-4 combined with exclusive 50Gy external RT while the CROSS trial... 
Journal Article
Journal Article
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2012, Volume 19, Issue 13, p. 4314
BRAF .sup.V600 mutations are frequent in melanomas, and BRAF.sup.V600-targeted therapy have dramatic, but often transitory, efficacy in stage IV patients.... 
Prognosis | Gene mutations | Analysis | Surgery | DNA | Melanoma | Genetic aspects | Metastasis | Public health
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2008, Volume 45, Issue 7, pp. 1175 - 1183
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 4_suppl, pp. 77 - 77
77 Background: 11C or 18F-labeled choline PET/CT has led to better understanding of the lymph drainage pattern of prostate cancer. It can provide radiation... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 184 - 190
Journal Article
Drugs & Aging, ISSN 1170-229X, 6/2016, Volume 33, Issue 6, pp. 419 - 425
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15, pp. 1748 - 1756
Purpose Up to 30% of patients who undergo radiation for intermediate-or high-risk localized prostate cancer relapse biochemically within 5 years. We assessed... 
PHASE-III TRIAL | THERAPY | ONCOLOGY | DEPRIVATION | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | RADIOTHERAPY | RTOG | DURATION
Journal Article